Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06976489
PHASE1
The Food Effect on PK Characteristics and Safety Profiles of PA-111
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of PA-111 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-05
Completion Date
2025-07
Last Updated
2025-05-16
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
PA-111
PA-111 1Tab., Per Oral
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea